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Abstract 
Background: Recombinant protein production can be stressful to the host organism. The extent of stress is deter-
mined by the specific properties of the recombinant transcript and protein, by the rates of transcription and transla-
tion, and by the environmental conditions encountered during the production process.
Results: The impact of the transcription of the T7-promoter controlled genes encoding human basic fibroblast 
growth factor (hFGF-2) and green fluorescent protein (GFP) as well as the translation into the recombinant protein on 
the growth properties of the production host E. coli BL21(DE3) were investigated. This was done by using expression 
vectors where the promoter region or the ribosome binding site(s) or both were removed. It is shown that already 
transcription without protein translation imposes a metabolic burden on the host cell. Translation of the transcript 
into large amounts of a properly folded protein does not show any effect on cell growth in the best case, e.g. high-
level production of GFP in Luria–Bertani medium. However, translation appears to contribute to the metabolic burden 
if it is connected to protein folding associated problems, e.g. inclusion body formation.
Conclusion: The so-called metabolic burden of recombinant protein production is mainly attributed to transcription 
but can be enhanced through translation and those processes following translation (e.g. protein folding and degrada-
tion, heat-shock responses).
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Background
The most common E. coli-based expression system is 
the bacteriophage T7 RNA polymerase and T7 pro-
moter controlled gene expression combination. IPTG-
induction of the chromosomally encoded bacteriophage 
T7 RNA polymerase leads to high level expression of T7 
promoter-controlled genes and correspondingly high 
recombinant protein titers. High level recombinant pro-
tein production in Escherichia coli frequently leads to 
an impact on host cell metabolism detectable through 
growth retardation and generally known as “metabolic 
burden” [1, 2]. The factors contributing to the metabolic 
burden are multifaceted depending on the host/vector 
combination and on the properties of the encoded gene 
with its transcription and translation products as well 
as on the environmental conditions encountered during 
the production process [3–6]. The prime reasons for the 
protein production related metabolic burden have been 
attributed to protein translation and protein folding [1, 
6] as well as to transcription and plasmid amplification 
related processes [7–9]. However, production of the same 
protein under identical conditions in the same host/vec-
tor combination but with single codon exchanges can 
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suggesting that the phenomenon is even more complex 
than anticipated.
In this contribution we analyze the impact of T7-pro-
moter-controlled recombinant gene expression on the 
host cell metabolism using two different model proteins, 
the difficult-to-fold human basic fibroblast growth fac-
tor (hFGF-2) with its high propensity to form inclusion 
bodies in E. coli and the easy-to-fold green fluorescent 
protein (GFP) mainly produced as soluble protein. For 
both examples we generated a set of expression vectors in 
which either the ribosome binding site (RBS) or the pro-
moter region or both were removed in order to analyze 
if the plasmid itself, the transcription of the recombinant 
gene, the translation into the protein product and/or pro-
tein folding related processes have an impact on host cell 
metabolism.
Results
Different proteins induce different growth inhibitions
The production of recombinant proteins can impair cel-
lular growth detectable through a slower increase in cell 
mass or even complete growth inhibition, slower car-
bon substrate uptake, and reduced respiratory activity. 
The extent of this inhibition is strongly influenced by the 
properties of the recombinant protein, a phenomenon 
noticeable when different proteins are being produced 
in the same host strain/expression system combina-
tion under identical production conditions (Fig.  1). For 
example, the production of hFGF-2, a protein partly 
produced as soluble protein and partly in form of inclu-
sion bodies, leads to a strong impact on bacterial growth 
([14–16], Fig. 1a). On the other hand, production of the 
green fluorescent protein (GFP), mainly produced as 
soluble protein in E. coli, impairs bacterial growth only 
marginally (Fig.  1b). Although this protein is produced 
in larger amounts at identical conditions compared to 
hFGF-2, production of GFP leads to a less severe decline 
of growth and metabolic activities (Fig. 1).
To distinguish if recombinant protein synthesis and/
or transcription of the recombinant gene are respon-
sible for the growth inhibitory effect a set of modified 
expression vectors was constructed. All expression vec-
tors carried a gene encoding a recombinant protein 
(hFGF-2 or GFP) with the original T7-based produc-
tion vectors containing in front of the target gene the 
T7 promoter and a ribosome binding site (RBS). One 
set of expression vectors was modified in such a way 
that transcription of the recombinant gene was allowed 
by IPTG addition but translation into the protein prod-
uct omitted by removal of the RBS. In a second set of 
expression vectors the promoter region was removed to 
prevent transcription of the recombinant gene. And in 
a third set of expression vectors the promoter region as 
well as the RBS were removed.
Already transcription of the recombinant gene causes 
growth inhibition
Cells of E. coli BL21(DE3) transformed with these dif-
ferent types of plasmids carrying the gene encoding 
hFGF-2 were grown in shake flask cultures in complex 
Luria–Bertani medium as well as in defined glucose-
supplemented mineral salt medium and cell growth was 
followed after IPTG addition (Fig. 2). Cells carrying the 
production vectors with intact promoter region and 
RBS revealed the expected growth inhibition in both 
types of media (Fig. 2a, b). Cells carrying the plasmids 
without RBS but intact promoter region also revealed 
growth inhibition upon IPTG addition showing that 
already enhanced recombinant gene transcription with-
out recombinant protein synthesis negatively impacts 
cell growth (Fig. 2a, b). However, in both types of media 
the growth inhibition was intensified when hFGF-2 was 
produced. SDS-PAGE analyses verified the presence of 
hFGF-2 in induced cells carrying the production vec-
tor with intact promoter region and RBS and absence 
in those induced cells transformed with the expres-
sion vector where the RBS in front of the hFGF-2 gene 
was removed (Fig. 3). Compared to transcript levels of 
the tufA gene, encoding the major housekeeping pro-
tein and elongation factor EF-Tu, transcript levels of 
hFGF-2 were largely enhanced in both types of trans-
formed cells, carrying the plasmid with intact pro-
moter region with and without RBS, after induction in 
LB (Fig. 4a) as well as in defined medium (Fig. 4b). For 
example, in cells carrying the original expression vector 
and induced in LB medium hFGF-2 transcripts reached 
more than 2000 times higher levels than those from the 
tufA gene. Non-induced control cells and induced con-
trol cells transformed with the vectors where the pro-
moter region in front of the hFGF-2 gene was removed 
did not produce hFGF-2 (Fig. 3) and only revealed basal 
transcripts levels of the plasmid-encoded hFGF-2 gene 
(Fig. 4). Induced control cells carrying expression vec-
tors without intact promoter region and the induced 
host E. coli BL21(DE3) not carrying any expression vec-
tor revealed the same marginal almost undetectable 
growth inhibition compared to the non-induced cells 
(Fig.  2c, d) demonstrating that plasmid maintenance 
and constitutive expression of plasmid encoded (antibi-
otic resistance) genes do not lead to any growth inhibi-
tion. A marginal growth retardation can be attributed 
to induced expression and synthesis of the chromosom-
ally encoded T7 RNA polymerase (Fig. 2d).
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Recombinant protein translation itself does not cause 
growth inhibition
In another set of experiments cells carrying the GFP 
encoding production vectors with intact promoter region 
(with and without RBS) were grown in shake flask cul-
tures in complex Luria–Bertani medium as well as in 
defined glucose-supplemented mineral salt medium and 
cell growth was followed after IPTG addition (Fig.  5). 
These experiments revealed for cells carrying the pro-
duction vector with intact promoter region and RBS the 
expected growth inhibition in both types of media, but 
less pronounced compared to hFGF-2 producing cells 
(Fig. 5a, b versus Fig. 2a, b).
Interestingly, cells carrying the plasmid without RBS 
but intact promoter region in front of the GFP gene 
revealed the same growth inhibition in LB medium upon 
IPTG addition as those cells transformed with the plas-
mid having the intact promoter region as well as the 
RBS (Fig.  5a) suggesting that only recombinant gene 
transcription but not protein translation itself contrib-
utes to growth inhibition. The presence and absence 
of the recombinant GFP in induced cells carrying the 
expression vector with and without RBS was  proven by 
SDS-PAGE analysis, respectively (Fig.  6) as well as the 
presence of elevated GFP transcript levels in both types 
of transformed cells upon induction in LB medium 
1414
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Fig. 1 Growth inhibition resulting from the production of different recombinant proteins. Production of a, c hFGF-2 and b, d GFP using E. coli BL21 
(DE3) as expression host was carried out in a, b Fernbach flasks with baffles and in c, d bioreactor batch cultures employing a defined mineral salt 
medium with glucose as carbon substrate. a, b OD600 (circles), glucose (squares) and SDS-PAGE analysis of target protein production (S: soluble, 
and I: insoluble cell protein of control and producing cells, the positions of target proteins are indicated) are shown. c, d Carbon dioxide (CTR, green 
lines) and oxygen transfer rates (OTR, blue lines) as well as dissolved oxygen concentrations (black and gray lines) are given. The arrows indicate 
the time point of IPTG addition to a final concentration of 0.25 mM in production experiments. Dark colored symbols and lines correspond to 
production experiments. Light colored lines and open gray symbols correspond to control experiments where IPTG addition was omitted. Data are 
presented as mean ± SD, n = 2
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(Fig.  7). Thus, the data prove that transcription of the 
GFP gene contributes to growth inhibition, however, 
synthesis of the GFP protein in LB medium is without 
impact on cell growth. 
Recombinant protein folding associated problems 
contribute to growth inhibition
During induction in defined glucose-supplemented min-
eral salt medium, however, cells carrying the GFP encod-
ing expression vector with the intact promoter region 
as well as the RBS exhibited a higher growth inhibition 
than those cells carrying the plasmid with intact pro-
moter region but without RBS (Fig.  5b). Again, SDS-
PAGE analyses revealed the presence of GFP in induced 
cells carrying the production vector with intact promoter 
region and RBS but not in those induced cells trans-
formed with the expression where the RBS was removed 
(Fig. 6). Also, real-time PCR analysis proved the presence 
of GFP mRNA in both types of transformed cells (Fig. 7). 
Thus, synthesis of recombinant GFP protein in defined 
glucose-supplemented mineral salt medium augments 
the recombinant gene transcription mediated growth 
inhibition.
SDS-PAGE analysis of the soluble and insoluble cell 
fraction of E. coli BL21(DE3) producing either hFGF-2 or 
GFP on complex Luria–Bertani or glucose-supplemented 
mineral salt medium revealed that on both types of 
media the majority of hFGF-2 aggregates into inclusion 
a b
c d






































































Fig. 2 Already transcription of the recombinant gene causes growth inhibition. Growth properties of E. coli BL21 (DE3) with expression vectors 
carrying the gene encoding hFGF-2 in shake-flask cultures with a Luria–Bertani (LB) or b defined glucose-supplemented mineral salt medium. 
Growth of cells carrying the original expression vector with promoter region and with RBS (squares) and the expression vector with promoter 
region but without RBS in front of the hFGF-2 gene (triangles). c Growth of cells on LB medium carrying the expression vector without promoter 
region but with RBS (circles) and without promoter region and without RBS (diamonds). d Control cultures of cells without any expression vector 
growing on LB medium (stars). Full black symbols always correspond to IPTG induced cultures and open gray symbols to cultures where IPTG 
addition was omitted. The time-point of IPTG addition to a final concentration of 0.5 mM is indicated by an arrow. Data are presented as mean ± SD, 
n = 4
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bodies (Fig.  3). GFP, on the other hand, does not form 
aggregates during growth on Luria–Bertani medium 
(Fig. 5). However, during production on glucose-supple-
mented mineral salt medium also GFP aggregates partly 
into inclusion bodies although the majority of the protein 
is still found in the soluble cell fraction (Fig.  6). These 
findings show that transcription of the recombinant gene 
clearly contributes to the metabolic burden but recombi-
nant protein translation only if it is connected of protein 
folding associated problems, e.g. formation of inclusion 
bodies.
Growth inhibition also caused by induction of the “empty” 
expression vector
Finally, the growth properties of E. coli BL21(DE3) car-
rying the “empty” expression vector pET28c or pET29c 
were analyzed. Short transcripts with a RBS are encoded 
downstream of the T7 promoter (pET28c: 225 bp encod-
ing a protein of 8.3  kDa and pET29c: 225  bp encoding 
a protein of 8.5  kDa). Surprisingly, both transformants 
showed a strong growth inhibition upon IPTG induction 
even stronger than the hFGF-2 producing stain (Fig.  8, 
data only shown for pET28c). SDS-PAGE analysis of 
induced cells revealed a protein at the expected position 
in E. coli BL21(DE3):pET29c mainly found in the insolu-
ble cell fraction (data not shown). However, no protein 
band was found in induced E. coli BL21(DE3):pET28c 
at the expected molecular mass of 8.3  kDa (data not 
shown) suggesting stalled ribosomes or proteolytic deg-












Fig. 3 hFGF-2 production only detectable when promoter region 
and RBS are present. SDS-PAGE analysis of IPTG induced cells carrying 
the gene encoding hFGF-2 growing on LB medium (lanes 1–8) and 
glucose supplemented mineral salt medium DNB (lanes 10–15) 
collected 4 h after induction. Lane 1: N,  T7+  RBS+ (non-induced 
control, total cell extract of cells containing the expression vector 
with promoter and with RBS in front of the hFGF-2 gene), lane 2: W, 
 T7+  RBS+ (induced cells with promoter and with RBS), lanes 3, 12: W, 
 T7+ ΔRBS (with promoter but without RBS), lanes 4, 13: W, ΔT7  RBS+ 
(without promoter but with RBS), lanes 5, 14: W, ΔT7 ΔRBS (without 
promoter and without RBS), lanes 6, 15: W, w/o plasmid (induced E. 
coli BL21(DE3) without expression vector), lanes 7, 10: S,  T7+  RBS+ 
(soluble) and lanes 8, 11: I,  T7+  RBS+ (insoluble cell fraction of induced 
cells containing the expression vector with promoter and with RBS). 
Lane 9: molecular mass marker, the position of hFGF-2 is indicated 
by an arrow. N: non-induced whole cell protein W: induced whole 













































































































































Fig. 4 hFGF-2 transcript levels under inducing and non-inducing conditions. a Transcript levels in E. coli BL21(DE3) transformed with expression 
vectors carrying the gene encoding hFGF-2 in shake-flask cultures with a Luria–Bertani (LB) medium or b defined glucose-supplemented mineral 
salt medium (DNB). Trancripts of genes encoding the major elongation factor EF-Tu (white bars) and hFGF-2 (gray bars) are shown in non-induced 
cells (open bars) and 4 h after IPTG induction (hatched bars).  T7+  RBS+: cells containing the expression vector with promoter and with RBS in front 
of the hFGF-2 gene;  T7+ ΔRBS: with promoter but without RBS; ΔT7  RBS+: without promoter but with RBS; ΔT7 ΔRBS: without promoter and without 
RBS; w/o plasmid: E. coli BL21(DE3) without expression vector. The inserts depict the same data as the main figures only at different scale. Transcripts 
of rrsH, were used as internal standard and artificially defined as 10,000. Data are presented as mean ± SD, n = 4
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without RBS but intact promoter region still showed 
strong growth inhibition upon IPTG addition but not as 
strong as the original pET28c vector with RBS (there is 
no additional RBS present in the short transcript) (Fig. 8). 
These data show that also short transcripts originating 
from “empty” expression vectors cause growth inhibition 
which can be intensified through corresponding down-
stream-processes of transcription (e.g. stalled ribosomes, 
folding problems of the translated protein peptide involv-
ing aggregation, degradation and the accompanying heat 
shock response).
Discussion
Reduction of the recombinant protein production asso-
ciated metabolic burden is generally accomplished by 
decreasing the expression of the recombinant gene. A 
sometimes detrimental growth inhibition with low lev-
els of the target protein can be overcome, for example, 
by replacing multicopy plasmids through chromosomal 
integration of the target gene [8, 9] or by utilizing strains/
constructs with reduced target gene promoter activ-
ity [13, 17, 18]. All these attempts reduce recombinant 
gene expression, alleviate the metabolic burden and at 
the same time increase the target protein amount. These 
findings suggest that not the amount of the recombi-
nant protein but rather recombinant gene transcription, 
the mRNA level or even the speed of translation are 
the major sources for the metabolic burden. Our data 
show that transcription or the transcript contributes to 
the metabolic burden but not protein translation itself. 
a b




































Fig. 5 Recombinant protein translation itself does not impair cell growth but folding associated problems contribute to growth inhibition. a 
Growth properties of E. coli BL21(DE3) with expression vectors carrying the gene encoding GFP in shake-flask cultures with a Luria–Bertani medium 
or b defined glucose-supplemented mineral salt medium (DNB). Growth of cells carrying the original expression vector with promoter region and 
with RBS (squares) and the expression vector with promoter region but without RBS in front of the hFGF-2 gene (triangles). Full black symbols 
always correspond to IPTG induced cultures and open gray symbols to cultures where IPTG addition was omitted. The time-point of IPTG addition 













Fig. 6 GFP only forms inclusion bodies during production on 
defined medium. SDS-PAGE analysis of IPTG induced cells carrying 
the gene encoding GFP growing on LB medium (lanes 1–6) and 
glucose supplemented mineral salt medium (lanes 8–13) collected 
4 h after induction. Lanes 1, 10: N,  T7+  RBS+ (non-induced controls, 
total cell extract of cells containing the expression vector with 
promoter and with RBS in front of the GFP gene), lanes 2, 11: W,  T7+ 
 RBS+ (induced cells with promoter and with RBS), lanes 3, 12: N,  T7+ 
ΔRBS (non induced controls with promoter but without RBS), lanes 
4, 13: W,  T7+ ΔRBS (induced cells with promoter but without RBS), 
lanes 5, 8: S,  T7+  RBS+ (soluble) and lanes 6, 9: I,  T7+  RBS+ (insoluble 
cell fraction of induced cells containing the expression vector with 
promoter and with RBS). Lane 7: molecular mass marker, the position 
of GFP is indicated by an arrow. N: non-induced whole cell protein 
W: induced whole cell protein, S: induced soluble part, and I: induced 
insoluble part of whole cell protein
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Recombinant protein synthesis appears to add only to 
the metabolic burden if it is connected to protein fold-
ing related problems during production, e.g. inclusion 
body formation, proteolytic degradation and connected 
cell responses such as heat shock responses. In the best 
case, e.g. high-level production of GFP on LB medium, 
translation of the transcript into a properly folded pro-
tein does not show any effect on cell growth. This proves 
that elevated translation of a useless protein—a highly 
energy consuming process—does not have a compulsa-
tory negative effect on host cell growth. But a negative 
effect is clearly exerted through elevated transcription 
or elevated transcript levels. On the other hand, transla-
tion or those processes following translation can enhance 
the transcription related growth inhibition. In this case it 
might not always be possible to clearly assign this addi-
tional inhibitory effect to translation (e.g. stalled ribo-
somes [19]) or to processes following translation of the 
target protein e.g. inclusion body formation, proteolytic 
degradation and/or connected cell responses such as heat 
shock responses. Moreover, the effect can also be com-
binatorial, e.g. translation is too fast for a slow folding 
protein leading to the formation of inclusion bodies, and 
subsequently to an enhanced growth inhibition. This is 
presumably the case for hFGF-2. hFGF-2 is a slow folding 
protein [20] that readily forms inclusion bodies and elic-
its a strong heat-shock response during rapid production 
in batch cultures [16] this way most likely increasing the 
transcription related growth inhibition.
After attributing the recombinant protein production 
related “metabolic burden” originally more to protein 
synthesis related problems more evidence is nowadays 
accumulating that transcription or the transcript itself is 
the major factor of the recombinant protein production 
related growth inhibition. Recent studies on the produc-
tion of proteins with synonymous codons revealed that 
some codons, encoding the same amino acid, were inhib-
iting cell growth more severely than others [12, 13]. It 
was also shown that the toxicity of certain gene variants 




























































Fig. 7 GFP transcript levels under inducing and non-inducing conditions. Transcript levels in E. coli BL21(DE3) transformed with expression vectors 
carrying the gene encoding GFP in shake-flask cultures with Luria–Bertani (LB) medium or defined glucose-supplemented mineral salt medium 
(DNB). Trancripts of genes encoding the major elongation factor EF-Tu (white bars) and GFP (gray bars) are shown in non-induced cells (open bars) 
and 4 h after IPTG induction (hatched bars).  T7+  RBS+: cells containing the expression vector with promoter and with RBS in front of the GFP gene; 
 T7+ ΔRBS: with promoter but without RBS. The insert depicts the same data set as the main figure only at different scale. Transcripts of rrsH were 
used as internal standard and artificially defined as 10,000. Data are presented as mean ± SD, n = 4
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protein translation [13]. Moreover, it was found that the 
toxicity of certain mRNA sequences could not be related 
to plasmid abundance nor to the abundance of the 
encoded mRNA [13]. Mittal et  al. concluded that toxic 
RNA might interact with essential cellular components 
and interfere with their normal function through a mech-
anism not yet known [13]. Our findings are in line with 
the observation that certain mRNA elements impose a 
stronger metabolic burden than others and additionally 
show that excessive transcription or elevated amounts of 
recombinant mRNA in general lead to growth retarda-
tion although not necessarily to severe growth inhibition.
Materials and methods
Strain and plasmids
Escherichia coli BL21 (DE3) (Novagen, Germany) har-
boring the plasmids pET-29c-hFGF-2 [15] and pET-28c-
His6-GFP [21] were used for the production of hFGF-2 
and GFP, respectively. Both genes are codon-optimized 
and their sequences given in Knoerzer et  al. [22] and 
Crameri et  al. [23]. The codon adaptation index (CAI) 
was determined as 0.79 for hFGF-2 and 0.65 for GFP 
[24]. The modified plasmids with deletions of RBS site 
and/or T7 promoter region (Table  1) were constructed 
using  Q5® Site-Directed Mutagenesis Kit (New England 
Biolabs, USA). NEBaseChanger™ tool (New England 
Biolabs, USA) was used to design primer sequences and 
infer annealing temperatures. The detailed experimental 
conditions were according to manufacturer’s instruc-
tions. Sequences of parental and mutant plasmids were 
confirmed by Sanger sequencing (Microsynth Seqlab, 
Germany).
Medium and cultivation conditions
The composition of Luria–Bertani (LB) broth was as 
follows: 10  g  L−1 tryptone, 5  g  L−1 yeast extract, and 
5  g  L−1 NaCl. The pH was adjusted to pH 7 by NaOH 
before autoclaving. For solidification, 15 g  L−1 agar were 
added. The composition of the defined glucose-supple-
mented mineral salt medium (Defined Non-inducing 
Broth (DNB) [21]) was as follows: 12 g  L−1 glucose·H2O, 
1.2 g  L−1  MgSO4·7H2O, 4 g  L−1  (NH4)2HPO4, 13.3 g  L−1 
 KH2PO4, 1.7 g  L−1 citric acid·H2O, 100.8 mg  L−1 Fe(III) 
citrate, 2.1  mg  L−1  Na2MoO4·2H2O, 1.4  mg  L−1  CoCl2, 
12.3  mg  L−1  MnCl2·2H2O, 1.2  mg  L−1  CuCl2, 3  mg  L−1 
 H3BO3, 33.8 mg  L−1 Zn(CH3COOH)2·2H2O, 14.1 mg  L−1 
Titriplex III. The pH was adjusted at pH 6.8 by NaOH. 
Details of medium preparation are given elsewhere [21]. 














Fig. 8 Growth properties of E. coli BL21 (DE3) carrying the “empty” 
pET-28c expression vector. Cells carrying the original “empty” pET-28c 
expression vector with promoter region and RBS (circles) and the 
“empty” vector with promoter region but without RBS (diamonds) 
were grown in shake flask cultures in Luria–Bertani medium. Growth 
of cells carrying the original expression vector encoding hFGF-2 with 
promoter region and with RBS is revisited for a better comparison 
(broken lines, open squares). Black symbols always correspond to 
IPTG induced cultures and gray symbols to cultures where IPTG 
addition was omitted. The time-point of IPTG addition to a final 
concentration of 0.5 mM is indicated by an arrow. Data are presented 




pET-28cΔRBS Mutant plasmid with deletion of all RBSs (AAG GAG ) between T7 promoter and T7 terminator
pET-29c-hFGF-2 Parental plasmid for the production of hFGF-2 [15]
pET-29c-hFGF-2 ΔRBS Mutant plasmid with deletion of all RBSs (AAG GAG ) between T7 promoter and T7 terminator
pET-29c-hFGF-2 ΔT7 Mutant plasmid with deletion of T7 promoter region (TAA TAC GAC TCA CTA TAG G)
pET-29c-hFGF-2 ΔRBS & ΔT7 Mutant plasmid with deletion of all RBSs (AAG GAG ) between T7 promoter and T7 terminator 
as well as T7 promoter region (TAA TAC GAC TCA CTA TAG G)
pET-28c-His6-GFP Parental plasmid for the production of GFP [21]
pET-28c-His6-GFP ΔRBS Mutant plasmid with deletion of all RBSs (AAG GAG ) between T7 promoter and T7 terminator
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For plasmid maintenance, 50  mg  L−1 kanamycin were 
added to the medium.
Precultures were prepared essentially as described pre-
viously [21]: briefly, a single colony from LB agar plate 
was transferred to LB medium after overnight incuba-
tion at 30  °C. The cultures were shaken at 30  °C over-
night to inoculate the LB main cultures or at 30  °C for 
6  h to inoculate the DNB overnight pre-cultures. DNB 
pre-cultures were used to inoculate the DNB main cul-
tures. Shake flask cultivations were carried out using 1.8 
L Fernbach flasks with three baffles containing 200  mL 
medium at 30  °C and 180  rpm or 500  mL Erlenmeyer 
flasks containing 50  mL medium at 30  °C and 250  rpm 
using a shaker with an amplitude of 5 cm. During biore-
actor batch cultivations temperature, pH, aeration, and 
agitation speed were set at 30  °C, pH 6.9, 1.5 vvm and 
300 rpm, respectively. All cultures were IPTG-induced at 
mid-exponential phase when the optical density reached 
OD600 1.0–1.5. All cultivations were carried out at least 
in quadruplicate if not stated otherwise. Mean values and 
standard deviation are given.
Basic analytical procedures and calculations
Cell growth was monitored by measurement of the 
absorbance at 600  nm (OD600). For glucose analysis, 
the YSI 2300 STAT PlusTM glucose and lactate analyzer 
(YSI Life Sciences, USA) was used. Off-gas analysis was 
performed in bioreactor cultures using the BlueInOne 
gas analyzer (BlueSens, Germany). The carbon dioxide 
and oxygen transfer rates were calculated as described 
previously [25]. The dissolved oxygen concentration was 
determined using a polarographic dissolved oxygen sen-
sor (Mettler Toledo, Germany). For preparation of cell 
extracts and determination of soluble and insoluble prod-
uct fractions, cells were disrupted by BugBuster™ Pro-
tein Extraction Reagent (Novagen, USA) with rLysozyme 
and Benzonase according to manufacturer’s instructions. 
Soluble and insoluble cell fractions were separated by 
centrifugation at 17,000g and 4 °C for 30 min. SDS-PAGE 
analysis was performed in the Mini-PROTEAN Tetra 
Cell (Bio-Rad, USA) according to standard procedures 
and manufacturer’s instructions. After electrophoresis, 
proteins were visualized by colloidal Coomassie G-250 
staining [26].
RNA extraction
Cultivation samples were transferred to centrifuge tubes 
which were prefilled with an equal volume of inhibition 
solution (5%  H2O saturated phenol in ethanol). Cells 
were pelleted by centrifugation (17,000g and 4  °C for 
5  min) and the supernatant was removed. The pellets 
were resuspended in half the original volume of RNAlater 
solution (25 mM sodium citrate, pH 5.2, 10 mM EDTA, 
700  g  L−1 ammonium sulfate) and stored at −  70  °C. 
Before hot phenol RNA extraction, cells stored in RNAl-
ater solution were centrifuged at 17,000g and 4  °C for 
10 min. After discarding the supernatant, the pellets were 
resuspended in 900  µL DEPC-treated  H2O with 400 U 
 mL−1 rLysozyme (Merck, Germany). After addition of 
90 µL 10% SDS, samples were incubated at 800 rpm and 
27  °C for 10  min and subsequently heated at 65  °C for 
2  min. Afterwards, 100  µL 1  M sodium acetate, pH 5.2 
and 1 mL  H2O saturated phenol (pH < 7) were added to 
the samples. Samples were inverted several times to mix 
and incubated at 65  °C for 7  min. Every 40  s, the sam-
ples were inverted several times. After centrifugation at 
17,000g and 4  °C for 15 min, the aqueous top layer was 
transferred to a new tube. The same volume of chloro-
form was added. After complete mixing and subsequent 
centrifugation at 17,000g and 4 °C for 10 min, the aque-
ous top layer was again transferred to a new tube. To pre-
cipitate RNA, 100 µL 5 M NaCl and 1–2 mL cold ethanol 
(− 20 °C) were added. After centrifugation at 17,000g and 
4  °C for 20  min, the RNA precipitate was washed once 
with 75% ethanol, centrifuged again at 17,000g and 4  °C 
for 20 min and the supernatant was discarded. Air-dried 
RNA pellets were resuspended in nuclease-free water 
and stored at − 20 °C.
cDNA synthesis
27 μL reaction mixture containing 1 μg of total RNA and 
0.375 μg of random hexamer primer was heated to 65 °C 
for 5  min to melt secondary structure within the tem-
plate. After cooling immediately on ice for 1  min, 4  μL 
dNTPs (10 mM each), 1 μL M-MLV reverse transcriptase 
(Promega, USA) and 8 μL 5× Reaction Buffer were added 
to the reaction mixture. The reverse transcription was 
carried out at 37 °C for 1 h. The synthesized cDNA was 
stored at − 20 °C.
Table 2 Primers for qPCR
Gene Primer sequence 5′–3′ Tm (°C) Amplicon (bp)
rrsH Fw: TCA GCG GGG ATG AAG GGA GTA 
AAG 
58.0 209
Rev: GCC AGT ATC AGA TGC AGT TCC 
CAG 
57.4
tufA Fw: TTC TTC AAA GGC TAC CGT CCGC 57.1 211
Rev: GAA CTT TAG CAA CAA CGC CCGC 58.1
hFGF-2 Fw: AAG ACC CGA AAC GTC TGT ACTGC 57.1 215
Rev: GGT AAC GCA TTT GGA AGC CAGC 57.1
GFP Fw: TGG AAA ACT ACC TGT TCC CTGGC 56.6 198
Rev: CCT TCA AAC TTG ACT TCA GCA 
CGC 
57.3
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Quantitative real‑time PCR
qPCR primers (Table  2) were designed using Eurofins’s 
online PCR primer design tools (https ://www.eurofi nsge 
nomic s.eu/en/ecom/tools /pcr-prime r-desig n/, Euro-
fins Genomics, Germany). qPCR was performed in an 
IQ5 Multicolor Real-Time PCR Detection System (Bio-
Rad, USA) using  GoTaq® qPCR Master Mix (Promega, 
USA). Each 25 μL reaction mixture contained 12.5 μL of 
2× qPCR Master Mix, 0.5 μL cDNAs and 0.5 μL of each 
primer. Amplification conditions were 3 min at 95 °C, fol-
lowed by a three-steps cycle of denaturation at 95 °C for 
30 s, annealing at 57.5 °C for 30 s and extension at 72 °C 
for 30 s for a total of 50 cycles. All qPCR reactions were 
carried out in triplicate and mean values are given. 16S 
ribosomal RNA (rrsH) was used as the internal standard. 
Expressions of translation elongation factor EF-Tu (tufA), 
hFGF-2 and GFP genes were normalized to rrsH, whose 
relative gene expression was artificially defined as 10,000 
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